You just read:

FDA Advisory Committee Strongly Recommends Approval and Self-Administration of FIRAZYR® (icatibant) for the Treatment of Acute Attacks of Hereditary Angioedema

News provided by

Shire plc

23 Jun, 2011, 22:06 BST